Overactivation of STAT3 by interferon-alpha may negatively influence disease outcome in melanoma patients

Autor:	Kovarík J, Ales Kovarik, Ladislav Dušek, L. Adamkova Humpolikova, Lauerová L, V. Boudny
Rok vydání:	2008
Předmět:	Cancer Research Oncology biology Disease outcome business.industry Melanoma Cancer research biology.protein medicine Alpha interferon STAT3 medicine.disease business
Zdroj:	European Journal of Cancer Supplements. 6:144
ISSN:	1359-6349
DOI:	10.1016/s1359-6349(08)71728-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8bc2b05bca7efac2d06199a5a8a6e064 https://doi.org/10.1016/s1359-6349(08)71728-2 Zobrazit plný text záznamu Full Text from ScienceDirect